Retatrutide 5mg

High-Purity Research Peptide

Retatrutide 5mg is supplied as a premium-quality lyophilised peptide intended exclusively for laboratory and scientific research. As an investigational triple receptor agonist targeting GLP-1, GIP and glucagon receptors, Retatrutide is currently the subject of ongoing metabolic research.

Each sterile vial contains 5mg of freeze-dried Retatrutide, providing researchers with a convenient format for experimental protocols requiring smaller quantities.

Product Features

• 5mg lyophilised Retatrutide per vial

• High-purity research material

• Sterile freeze-dried formulation

• Securely sealed vial for product integrity

• Suitable for laboratory and research environments

Storage

Store refrigerated at 2–8°C. Keep protected from moisture, heat and direct sunlight.

Important Information

For laboratory research use only.

Not approved for human or veterinary use. This product is not intended to diagnose, treat, cure or prevent any disease. Retatrutide remains an investigational compound and has not been approved by the Australian TGA for therapeutic use.